Shares of Shire PLC (NASDAQ:SHPG) saw strong trading volume on Friday . 966,248 shares were traded during trading, an increase of 25% from the previous session’s volume of 774,547 shares.The stock last traded at $191.92 and had previously closed at $188.50.

A number of research analysts recently weighed in on the stock. Shore Capital restated a “buy” rating on shares of Shire PLC in a research report on Tuesday. Jefferies Group restated a “buy” rating on shares of Shire PLC in a research report on Wednesday, August 17th. TheStreet downgraded shares of Shire PLC to a “hold” rating in a research report on Thursday, August 4th. Zacks Investment Research upgraded shares of Shire PLC from a “sell” rating to a “hold” rating in a research report on Thursday, August 4th. Finally, RBC Capital Markets reiterated an “outperform” rating on shares of Shire PLC in a research report on Wednesday, August 3rd. Four equities research analysts have rated the stock with a hold rating and twenty-four have given a buy rating to the company. Shire PLC has a consensus rating of “Buy” and an average target price of $237.41.

The company has a market capitalization of $57.30 billion and a P/E ratio of 39.98. The firm’s 50 day moving average price is $195.29 and its 200 day moving average price is $180.79.

Shire PLC (NASDAQ:SHPG) last posted its quarterly earnings data on Tuesday, August 2nd. The biopharmaceutical company reported $3.38 earnings per share for the quarter, topping the Zacks’ consensus estimate of $3.03 by $0.35. During the same quarter in the prior year, the company posted $2.63 earnings per share. The company had revenue of $2.43 million for the quarter, compared to analyst estimates of $2.28 billion. The business’s revenue was up 55.9% on a year-over-year basis. Equities research analysts forecast that Shire PLC will post $12.93 earnings per share for the current fiscal year.

The firm also recently announced a dividend, which will be paid on Friday, October 7th. Stockholders of record on Friday, September 9th will be given a $0.139 dividend. The ex-dividend date of this dividend is Wednesday, September 7th.

Shire plc is a biotech company. The Company, along with its subsidiaries, is engaged in developing and marketing medicines for patients with rare diseases and other select conditions. The Company operates in the segment of research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.